Showing results (281-290 of 588) with videos related to
Sort By:
Pageof 59
Anticancer Research|April 30, 2014
Contemporary review of large adrenal tumors in a tertiary referral centerDiane Mege, David Taieb, Aoife Lowery, et al.Endocrine|May 11, 2020
MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectivesVincent Amodru, David Taieb, Carole Guerin, et al.Annales D'Endocrinologie|June 9, 2026
Redefining the role of surgery in hypophysitis: our experience, and a literature reviewLéa Miquel, Benoit Testud, Nicolas Sahakian, et al.European Journal of Endocrinology|September 29, 2021
Acromegaly in remission: a view from the partnerRachel Fourneaux, Marie Vermalle, Frederique Albarel, et al.Human Molecular Genetics|August 24, 2010
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell linesYu Wang, Todd Romigh, Xin He, et al.Journal of Medical Genetics|May 21, 2017
A retrospective chart review of the features of PTEN hamartoma tumour syndrome in childrenEmily Hansen-Kiss, Sarah Beinkampen, Brent Adler, et al.Human Molecular Genetics|December 20, 2011
Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinomaGurkan Bebek, Kristi L Bennett, Pauline Funchain, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanomaMohamed H Abdel-Rahman, Ying Yang, Xiao-Ping Zhou, et al.Cleveland Clinic Journal of Medicine|February 5, 2020
Pharmacogenomics: An evolving clinical tool for precision medicineJennifer K Hockings, Amy L Pasternak, Angelika L Erwin, et al.The New England Journal of Medicine|December 21, 2007
Breast-cancer stromal cells with TP53 mutations and nodal metastasesAttila Patocs, Li Zhang, Yaomin Xu, et al.Pageof 59